Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Even at lower doses, semaglutide 1.0 mg achieved a 42% CRP reduction in STEP 2
WEIGHT-LOSS DRUGS' IMPACT ON CANCER RISK REVEALED IN NEW STUDY The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and "exacerbating mood disturbances." The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this "potential risk." But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K
Bhatti JA, Nathens AB, Thiruchelvam D, Grantcharov T, Goldstein BI, Redelmeier DA
Im producing What Linkedin Doesnt Say About Wendy Mullin, founder of Built By Wendy
US$ 25.95
US$ 29.03
US$ 26.87
